Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

App-y days as NetScientific’s portfolio company Wanda launches phone app

The app aims to empower women to improve the health of their hearts by offering support, education and guidance

Netscientific PLC's (LON:NSCI) digital health portfolio company Wanda has launched a phone app today aimed at helping women improve the health of their hearts.

MyWanda, the first app of its kind, will offer personalised daily tips, advice and inspiration to encourage women to develop “heart healthy behaviours”.

“We’re excited to bring a technology solution to market that can truly inform, motivate and support women to take better care of their hearts,” said Wanda chief executive Steve Curd.

NetScientific’s chief executive François Martelet added: “This is an important milestone for Wanda and is in line with the company’s strategy to expand its platform of mobile applications to capture patients earlier in their disease trajectory.”

Heart disease is the number one killer of women in America, although San Francisco-based Wanda estimates that around 80% of cases are preventable through education and lifestyle changes.

The company has called the new app, which is available on the US iTunes App Store, a “revolution in healthcare”.

As well as helping women to take control of their health, the app will add to Wanda’s current data and understanding of women’s heart health.

Shares in NetScientific were down 1p, or 1.3%, to 76p.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK